Clinical trials
Phase 2 Hemolysis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Withdrawn | 3 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Emory University | 1 |
| Forma Therapeutics, Inc. | 1 |
| InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 1 |
| Kezar Life Sciences, Inc. | 1 |
| Mayo Clinic | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemolysis | 8 |
| Anemia | 3 |
| Hematologic Diseases | 3 |
| Anemia, Sickle Cell | 2 |
| Genetic Diseases, Inborn | 2 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Cardiovascular Diseases | 1 |
| Hemoglobinopathies | 1 |
| Hepatitis C | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.